EDWARD ALAN HIRSCHOWITZ, MD
Osteopathic Medicine at Limestone, Lexington, KY

License number
Kentucky 34491
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Kentucky 34491
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Kentucky 34491
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
740 S Limestone ROOM K528, Lexington, KY 40536
Phone
(859) 323-5045

Personal information

See more information about EDWARD ALAN HIRSCHOWITZ at radaris.com
Name
Address
Phone
Edward Hirschowitz
216 E Bell Ct, Lexington, KY 40508
Edward Hirschowitz
306 Dudley Rd, Lexington, KY 40502
Edward Hirschowitz
1406 Cochran Rd, Lexington, KY 40502
Edward Hirschowitz
144 Hanover Ave, Lexington, KY 40502
Edward Hirschowitz
216 Bell Ct, Lexington, KY 40508

Professional information

Edward A Hirschowitz Photo 1

Dr. Edward A Hirschowitz, Lexington KY - MD (Doctor of Medicine)

Specialties:
Critical Care Medicine, Pulmonology
Address:
MARKEY CANCER
740 SOUTH Limestone, Lexington 40508
(859) 323-5045 (Phone), (859) 587-2418 (Fax)
Certifications:
Critical Care Medicine, 1997, Internal Medicine, 1992, Pulmonary Disease, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Alabama At Birmingham
Graduated: 1989
Ny and Presby Hp Cornell Campus


Edward Hirschowitz Photo 2

Lung Cancer Diagnostic Assay

US Patent:
2012023, Sep 13, 2012
Filed:
Mar 26, 2012
Appl. No.:
13/430474
Inventors:
Edward A. Hirschowitz - Lexington KY, US
Li Zhong - Walnut CA, US
Arnold J. Stromberg - Lexington KY, US
Nada H. Khattar - Lexington KY, US
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
A method for selecting a person at risk for lung cancer to undergo radiographic testing is provided. The method provides for the identification of markers for lung cancer in a population of patients that have not previously diagnosed with the disease. The markers identify autoantibodies present in a fluid sample of a patient who may not show other symptoms of lung cancer.


Edward Hirschowitz Photo 3

Associate Professor At University Of Kentucky

Position:
Associate Professor at University of Kentucky
Location:
Lexington, Kentucky Area
Industry:
Medical Practice
Work:
University of Kentucky - Associate Professor


Edward Alan Hirschowitz Photo 4

Edward Alan Hirschowitz, Lexington KY

Specialties:
Pulmonologist
Address:
740 S Limestone, Lexington, KY 40508
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)


Edward Hirschowitz Photo 5

Lung Cancer Diagnotic Assay

US Patent:
2010009, Apr 15, 2010
Filed:
Jul 6, 2007
Appl. No.:
12/309145
Inventors:
Nada H. Khattar - Lexington KY, US
Edward A. Hirschowitz - Lexington KY, US
Li Zhong - Walnut CA, US
Arnold J. Stromberg - Lexington KY, US
International Classification:
G01N 33/543, C07K 2/00, C07K 16/00, C40B 40/10
US Classification:
436518, 530300, 5303871, 506 18
Abstract:
A diagnostic assay for determining presence of lung cancer in a patient depends, in part, on ascertaining the presence of an antibody associated with lung cancer using random polypeptides. The assay predicted lung cancer prior to evidence of radiographically detectable cancer tissue.


Edward Alan Hirschowitz Photo 6

Edward Alan Hirschowitz, Lexington KY

Specialties:
Internal Medicine, Pulmonary Disease, Critical Care Medicine
Work:
UK Dept of Pulmonology
740 S Limestone St, Lexington, KY 40536
Education:
University of Alabama at Birmingham (1989)


Edward Hirschowitz Photo 7

Lung Cancer Diagnostic Assay

US Patent:
2009019, Aug 6, 2009
Filed:
Nov 10, 2006
Appl. No.:
12/093082
Inventors:
Edward A. Hirschowitz - Lexington KY, US
Li Zhong - Walnut CA, US
Arnold J. Stromberg - Lexington KY, US
Nada H. Khattar - Lexington KY, US
Assignee:
UNIVERSITY OF KENTUCKY - Lexington KY
International Classification:
G01N 33/574, C12M 1/00
US Classification:
435 723, 4352872
Abstract:
A diagnostic assay for determining presence of lung cancer in a patient depends, in part, on ascertaining the presence of an antibody associated with lung cancer. The assay predicted lung cancer prior to evidence of radiographically detectable cancer tissue.